LabCentral to Open Next-Stage Facility for Growing Life-Science Companies, Supported by Pfizer
September 21, 2017
In December 2017, LabCentral plans to open LabCentral 610. Generously supported by Pfizer Inc., the 33,000-square-foot facility will be on the third floor of Pfizer’s Kendall Square Worldwide Research and Development building across a shared driveway from LabCentral’s original site. It will become home to up to six early- to mid-stage companies “graduating” from or out-growing the current LabCentral space, as well as other startups interested in securing space in the thriving bioscience Kendall Square neighborhood. Eligible startups include those with high-impact science, excellent execution, and significant prospects for achieving scientific and business success whose space needs exceed current LabCentral offerings.
Photo credit: Lindsay Michelle Crockett, LabCentral, Inc.